Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic

Am J Psychiatry. 2001 Apr;158(4):650-1. doi: 10.1176/appi.ajp.158.4.650-a.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Adult
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines
  • Drug Therapy, Combination
  • Emergency Service, Hospital
  • Female
  • Haloperidol / adverse effects*
  • Haloperidol / therapeutic use
  • Humans
  • Neuroleptic Malignant Syndrome / etiology*
  • Olanzapine
  • Pirenzepine / adverse effects
  • Pirenzepine / analogs & derivatives*
  • Pirenzepine / therapeutic use*
  • Schizophrenia / drug therapy*

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Pirenzepine
  • Haloperidol
  • Olanzapine